Skip to main content

Palbociclib

Meaning

Palbociclib is a targeted oral therapeutic agent classified as a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6, primarily indicated for use in combination with endocrine therapy to treat hormone receptor-positive, HER2-negative (HR+/HER2-) advanced or metastatic breast cancer. This drug functions by selectively interfering with the cell cycle progression of cancer cells, thereby significantly slowing down tumor proliferation. It represents a crucial advancement in the strategy of overcoming endocrine resistance in this specific patient population.